Reliability and validity of the functional assessment of cancer therapy-ovarian

被引:213
作者
Basen-Engquist, K
Bodurka-Bevers, D
Fitzgerad, MA
Webster, K
Cella, D
Hu, SH
Gershenson, DM
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Behav Sci, Houston, TX 77030 USA
[2] Evanston NW Healthcare, Ctr Outcomes Res & Educ, Evanston, IL USA
[3] Northwestern Univ, Evanston, IL USA
关键词
D O I
10.1200/JCO.2001.19.6.1809
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To report the reliability and validity of the Functional Assessment of Cancer Therapy-Ovarian (FACT-O) in a consecutive series of outpatients with epithelial ovarian cancer. Patients and Methods: Two hundred thirty-two ovarian cancer patients attending an outpatients gynecologic oncology clinic completed questionnaires at baseline. The patients' FACT-O scores were compared with their performance status, disease stage, treatment status, and other factors hypothesized to be related to quality of life. Patients received a second questionnaire either one week after baseline to assess the instrument's test-retest reliability and/or two months after baseline to evaluate its sensitivity to change in performance status. Results: Infernal consistency and test-retest reliability of the FACT-O were adequate. Overall, the scales correlated with other measures as expected; all correlations were in the hypothesized direction, patients with advanced disease, poor performance status, and who were receiving active treatment had lower scores on physical, functional, and ovarian cancer-specific scales. The total FACT-O and emotional well-being scores were lower for patients with poor performance status and patients in active treatment. The FACT-O total and all subscale scores except emotional well-being were sensitive to decreases in performance status. Conclusion: Overall, the FACT-O provides a reliable and valid assessment of the quality of life of women with ovarian cancer, and is appropriate as a brief quality of life assessment in clinical trials and descriptive studies. (C) 2001 by American Society of Clinical Oncology.
引用
收藏
页码:1809 / 1817
页数:9
相关论文
共 37 条
[11]   Absorption, social desirability, and symptoms in a behavioral medicine population [J].
Gick, M ;
McLeod, C ;
Hulihan, D .
JOURNAL OF NERVOUS AND MENTAL DISEASE, 1997, 185 (07) :454-458
[12]  
Huang CY, 1998, J CLIN PSYCHOL, V54, P517, DOI 10.1002/(SICI)1097-4679(199806)54:4<517::AID-JCLP13>3.0.CO
[13]  
2-I
[14]  
KORNBLITH AB, 1995, GYNECOL ONCOL, V59, P231
[15]   SOCIAL DESIRABILITY IN MEASURES OF SUBJECTIVE WELL-BEING - AGE COMPARISONS [J].
KOZMA, A ;
STONES, MJ .
SOCIAL INDICATORS RESEARCH, 1988, 20 (01) :1-14
[16]  
List MA, 1996, CANCER-AM CANCER SOC, V77, P2294, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2294::AID-CNCR17>3.3.CO
[17]  
2-T
[18]  
Lushene R., 1983, STATE TRAIT ANXIETY, DOI [10.1037/t06496-000, DOI 10.1037/T06496-000]
[19]   Quality of life measurement in bone marrow transplantation: Development of the functional assessment of cancer therapy-bone marrow transplant (FACT-BMT) scale [J].
McQuellon, RP ;
Russell, GB ;
Cella, DF ;
Craven, BL ;
Brady, M ;
Bonomi, A ;
Hurd, DD .
BONE MARROW TRANSPLANTATION, 1997, 19 (04) :357-368
[20]  
Moos RH., 1994, Family Environment Scale Manual